Wave Life Sciences (WVE) Non-Current Debt (2016 - 2018)
Wave Life Sciences (WVE) posted Non-Current Debt of $9.2 million for Q4 2018, up 12.37% on a QoQ basis from $8.2 million in Q3 2018, and up 198.87% year-over-year from $3.1 million in Q4 2017.
Wave Life Sciences (WVE) Non-Current Debt (2016 - 2018) Analysis & Trends
Wave Life Sciences' Non-Current Debt history runs 3 years deep, the most recent figure standing at $9.2 million for Q4 2018.
- Quarterly Non-Current Debt rose 198.87% year-over-year to $9.2 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $9.2 million (up 198.87% YoY) and the FY2018 annual result came in at $9.2 million, up 198.87% from the prior year.
- Non-Current Debt was $9.2 million for Q4 2018 at Wave Life Sciences, up from $8.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $9.2 million in Q4 2018 and bottomed at $116000.0 in Q4 2016.
- A 3-year average of $4.1 million and a median of $3.1 million in 2017 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2017 — Non-Current Debt jumped 2567.24% — and 2018, when it surged 194.67%.
- Wave Life Sciences' Non-Current Debt stood at $116000.0 in 2016, then soared by 2567.24% to $3.1 million in 2017, then surged by 198.87% to $9.2 million in 2018.
- Business Quant data shows WVE's Non-Current Debt at $9.2 million in Q4 2018, $8.2 million in Q3 2018, and $6.5 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9.25 Mn |
| Sep 30, 2018 | 8.23 Mn |
| Jun 30, 2018 | 6.47 Mn |
| Mar 31, 2018 | 4.19 Mn |
| Dec 31, 2017 | 3.09 Mn |
| Sep 30, 2017 | 2.09 Mn |
| Jun 30, 2017 | 2.20 Mn |
| Mar 31, 2017 | 1.08 Mn |
| Dec 31, 2016 | 116,000.00 |